NutriSystem Inc (NASDAQ:NTRI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday. The brokerage presently has a $58.00 price target on the stock. Zacks Investment Research‘s price objective indicates a potential upside of 7.71% from the company’s current price.

According to Zacks, “NutriSystem is a leading provider of weight management products and services. They offer an at-home weight loss program based on portion-controlled, lower Glycemic Index prepared meals, weight loss plans, and private telephone and online support. “

Several other research analysts have also recently commented on NTRI. Craig Hallum set a $70.00 price target on NutriSystem and gave the stock a “buy” rating in a research note on Tuesday, July 18th. BidaskClub upgraded NutriSystem from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, July 19th. DA Davidson reiterated a “buy” rating and issued a $64.00 price target on shares of NutriSystem in a research note on Monday, July 24th. Lake Street Capital set a $73.00 price target on NutriSystem and gave the stock a “buy” rating in a research note on Thursday, July 27th. Finally, B. Riley reiterated a “buy” rating and issued a $74.00 price target on shares of NutriSystem in a research note on Friday, July 28th. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. NutriSystem currently has an average rating of “Buy” and an average target price of $67.44.

NutriSystem (NASDAQ:NTRI) traded up 3.21% on Friday, hitting $53.85. The stock had a trading volume of 1,042,873 shares. NutriSystem has a 12-month low of $30.11 and a 12-month high of $67.95. The company’s 50 day moving average is $55.33 and its 200 day moving average is $53.57. The firm has a market cap of $1.60 billion, a PE ratio of 33.36 and a beta of 1.15.

NutriSystem (NASDAQ:NTRI) last released its quarterly earnings results on Wednesday, October 25th. The company reported $0.49 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.46 by $0.03. NutriSystem had a return on equity of 49.69% and a net margin of 8.27%. The business had revenue of $158.10 million for the quarter, compared to analysts’ expectations of $155.21 million. During the same quarter in the previous year, the firm posted $0.27 earnings per share. The company’s revenue was up 26.9% compared to the same quarter last year. On average, equities research analysts expect that NutriSystem will post $1.91 EPS for the current fiscal year.

NutriSystem announced that its Board of Directors has initiated a stock buyback plan on Wednesday, October 25th that permits the company to buyback $50.00 million in outstanding shares. This buyback authorization permits the company to buy shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

TRADEMARK VIOLATION NOTICE: This article was posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/10/28/nutrisystem-inc-ntri-lifted-to-buy-at-zacks-investment-research.html.

In other NutriSystem news, insider Dawn M. Zier sold 29,100 shares of the company’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $54.00, for a total transaction of $1,571,400.00. Following the sale, the insider now owns 273,867 shares in the company, valued at $14,788,818. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jay Herratti sold 3,799 shares of the company’s stock in a transaction that occurred on Thursday, October 12th. The shares were sold at an average price of $60.00, for a total value of $227,940.00. The disclosure for this sale can be found here. Insiders have sold 91,355 shares of company stock worth $4,903,650 in the last 90 days. 2.40% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. FNY Partners Fund LP acquired a new stake in NutriSystem during the first quarter valued at approximately $111,000. Meeder Asset Management Inc. acquired a new stake in NutriSystem during the second quarter valued at approximately $106,000. Riverhead Capital Management LLC raised its stake in NutriSystem by 62.1% during the second quarter. Riverhead Capital Management LLC now owns 2,431 shares of the company’s stock valued at $126,000 after buying an additional 931 shares in the last quarter. Ameritas Investment Partners Inc. raised its stake in NutriSystem by 10.9% during the second quarter. Ameritas Investment Partners Inc. now owns 2,608 shares of the company’s stock valued at $136,000 after buying an additional 257 shares in the last quarter. Finally, Victory Capital Management Inc. raised its stake in NutriSystem by 17.7% during the second quarter. Victory Capital Management Inc. now owns 2,646 shares of the company’s stock valued at $138,000 after buying an additional 397 shares in the last quarter. Hedge funds and other institutional investors own 92.59% of the company’s stock.

NutriSystem Company Profile

Nutrisystem, Inc is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.

Get a free copy of the Zacks research report on NutriSystem (NTRI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem Inc and related companies with MarketBeat.com's FREE daily email newsletter.